Cargando…
Corrigendum to “Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression.” Kidney Int Rep. 2020;5:58–65
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056864/ https://www.ncbi.nlm.nih.gov/pubmed/32154464 http://dx.doi.org/10.1016/j.ekir.2020.01.024 |
Ejemplares similares
-
An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of Progression
por: Zand, Ladan, et al.
Publicado: (2019) -
Corrigendum to “Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in Developed Countries.” Kidney Int Rep. 2020;5:263–277
Publicado: (2020) -
Corrigendum to “Kimura T, Snijder R, Nozaki K. Diagnosis patterns of CKD and anemia in the Japanese population.” Kidney Int. Rep. 2020;5:694–705
Publicado: (2020) -
Corrigendum to “Narita I. Estimating Growth Rate by a Single Measurement of Kidney Volume in ADPKD.” Kidney Int Rep. 2020;5:1383–1384
Publicado: (2021) -
Corrigendum to “Cataldo E, Cinquantini F, Priola AM, et al. Spontaneous renal artery dissection in Ehler–Danlos syndrome.” Kidney Int Rep. 2019;4:1649–1652
Publicado: (2020)